Riboksin: imiyalelo zokusetyenziswa, inkcazo lepropati.

Drug "Riboxinum" umyalelo kwi isicelo ichaza nje ichiza kokuba uthethe inyathelo antihypoxic kunye antiarrhythmic. Ukuthatha inxaxheba ngqo kwi nethe glucose emzimbeni womntu, oko kunegalelo inkqubo kwananwe ngayo ngexesha hypoxia. Kwakhona, ichiza kuphucula iinkqubo pathways kwi nezihlunu imisipha intliziyo, iphucula izicwili nokuphefumla yaye kuphucula umsebenzi contractile kwentliziyo ka myocardium.

Ukubonakala ichiza "Riboksin" abstract ichaza njengoko amacwecwe bhanya wawutyabeka ukuba umbala ukusuka mthubi ukukhanya ukuze zikhanyise orange okuqaqambileyo. indawo kancinane uburhabaxa, uhlobo khaxa. Le esisebenza iphambili ukwakhiwa ichiza "Riboksin" i inosine.

Ichiza "Riboksin": ezibonisa ukuba ukusetyenziswa kunye balawule.

Le medicament singasebenza kuphela kagqirha, ukusetyenziswa elizimeleyo ngaphandle ngokupheleleyo. Xa zidityanisiwe unyango ngamachiza "Riboksin" umyalelo ncwadi incoma uthathe:

• Ø bekhubazekile kunye iziphene ezifunyenwe intliziyo ;
• ukuqina Ø;
• hepatitis Ø ezingapheliyo kunye oyingozi;
• engabalulekanga Ø;
• Ø arrhythmia waba kwenzeka ulawulo enyangayo, glycosides intliziyo;
• myocarditis Ø;
• insufficiency coronary Ø;
• iposi engabalulekanga Ø;
• Ø «intliziyo pulmonary";
• Ø of arrhythmias inhliziyo.

Kucetyiswa ukuba usebenzise ekulungiseleleni njengendlela farmakozaschity nandlela zokuqhubeka naluphi isebenzela kidney ekwanti.

Kwimiba ye umthamo ichiza "Riboksin" yemiyalezo uncoma zikhokelo zilandelayo. Enye okanye ezimbini zokuqala iintsuku ukuqala unyango kufuneka umda kwe-1 philisi okanye tablet amaxesha 3-4 emini. Ukuba akukho kukhona iimpawu komzimba kunye reactions, ithamo ukuya ekuqaleni yokwanda ngomhla wesithathu, ekhokelela 2-2.4 grams ngemini. Ikhosi reception medicament ithatha inyanga enye ukuya ezine kunye reactions ulawulo zonyango kunyanzelekile ukuba ichiza. "Riboxinum" yemiyalezo icebisa nisele phambi kokungenisa, okwenza ukuba ukufunxeka kwayo ngokupheleleyo.

Ichiza "Riboksin": Izimo, libanda, kunye neengcebiso.

Ekubeni ichiza kusetyenziswa ngexesha nothomalaliso indibanisela isifo sentliziyo, ukubaluleka ekhethekileyo ngokunjalo ukuhambelana yayo kunye nezinye iziyobisi. Xa iinaliti "Riboxinum" ayikhuthazwa uxutywe kwi isirinji efanayo nayo nayiphi na eminye imithi, njengoko oku kukhokelela imichiza indlela ayaziwa. Ngelo xesha ezithatha ichiza kunye senhliziyo glycosides iziphumo zazo Iziphumo ezidityanisiweyo ekuthintelweni of arrhythmias inhliziyo. Β-adrenergic blocker musa ukunciphisa isiphumo konwaywa ichiza "Riboxinum", isicelo yabo elifanayo kwixesha elivunyelweyo.

Izimo ekufumaneni echiza hyperuricemia, sifo, kwaye ubukho xa kukho ogulayo zobandlululo okanye hypersensitivity ukuya amacandelo ichiza. Kwimeko yokusilela wesigulane sezintso kwimfuno ichiza kufuneka kwenziwe kuphela xa kukho izikhokelo ezivela ezinzulu. lonke ikhondo unyango kuyimfuneko ukuba esweni umsebenzi zezintso.

Amatyala "Riboksin" libanda azifikelelwanga iphawulwe, iimpawu ayaziwa. Njengoko imiphumela emibi waphawula ziyabagulisa ngohlobo sokudlathuka kweenwele, sifo etsolo, ebukeka - ukunyuka okukhulu kumanqanaba urea egazini. Ngophuhliso yeziphumo ebezingalindelekanga ichiza kufuneka kupheliswa. Sebenzisa njengendlela likaxakeka yokuqeqesha eyayichasene umsebenzi kwentliziyo akuvumelekanga.